Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzo[a]Pyrene Ultralow Dose-Response Study
NCT03318978Phase 1Completed
- Sponsor
- Oregon State University
- Start
- Apr 2018
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Oregon State University. Primary endpoint: Peak Plasma Concentration. Started Apr 2018; status: completed.
Beyond the preview
Go deeper on NCT03318978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03318978.